Selman Renee Insider Trades

Insider Trading History

Track insider trading activity for Selman Renee. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Agile Therapeutics
Agile Therapeutics AGRX
Chief Commercial Officer
Holding Value $118k 78,083 shares
Last Trade
Jan 25, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.6B 35,000 shares
$332,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Commercial Officer
Holding Value $108k 71,628 shares
Last Trade
Jan 25, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.14B 6,455 shares
$332,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Commercial Officer
Holding Value $162k 107,000 shares
Last Trade
Jan 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.6B 120,200 shares
$346,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Commercial Officer
Holding Value $91.5k 60,583 shares
Last Trade
Aug 25, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.41B 7,250 shares
$333,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Commercial Officer
Holding Value $80.5k 53,333 shares
Last Trade
May 11, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$18.7B 53,333 shares
$350,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Commercial Officer
Holding Value $189k 125,000 shares
Last Trade
Jan 25, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.2B 160,000 shares
$226,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Commercial Officer
Holding Value $113k 75,000 shares
Last Trade
Jul 28, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.9B 75,000 shares
$678,000.00
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up